Anti-biofilm agents: Recent breakthrough against multi-drug resistant Staphylococcus aureus

Pathogens and Disease

Volumn 70, Issue 3, 2014, Pages 231-239

  Chung, Pooi Y ^a   Toh, Yien ^a  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

Anti biofilm agents; Quorum sensing; Staphylococcus aureus

Indexed keywords

NANOPARTICLE; NATURAL PRODUCT; SILVER; ANTIINFECTIVE AGENT; BIOLOGICAL PRODUCT; ION;

ANTIBIOTIC RESISTANCE; BACTERIOPHAGE; BACTERIUM ADHERENCE; BIOFILM; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; QUORUM SENSING; SHORT SURVEY; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; ANIMAL; CHEMISTRY; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; MULTIDRUG RESISTANCE; PHYSIOLOGY; STAPHYLOCOCCAL INFECTIONS;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL ADHESION; BACTERIOPHAGES; BIOFILMS; BIOLOGICAL PRODUCTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; IMMUNOTHERAPY; IONS; NANOPARTICLES; QUORUM SENSING; SIGNAL TRANSDUCTION; SILVER; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84916598780     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12141     Document Type: Short Survey

References (84)

1. Abraham NM, Lamlertthon S, Fowler VG., Jefferson KK (2012) Chelating agents exert distinct effects on biofilm formation in Staphylococcus aureus depending on strain background: role for clumping factor B. J Med Microbiol 61: 1062-1070.
2. Akiyama T, Miyamoto H, Yonekura Y, Tsukamoto M, Ando Y, Noda I, Sonohata M., Mawatari M (2013) Silver oxide-containing hydroxyapatite coating has in vivo antibacterial activity in the rat tibia. J Orthop Res 31: 1195-1200.
3. Anguita-Alonso P, Giacometti A, Cirioni O et al. (2007) RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation. Antimicrob Agents Chemother 51: 2594-2596.
4. Antonelli M, De Pascale G, Ranieri VM et al. (2012) Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive®) vs conventional catheters in intensive care unit patients. J Hosp Infect 82: 101-107.
5. Artini M, Papa R, Barbato G, Scoarughi GL, Cellini A, Morazzoni P, Bombardelli E., Selan L (2012) Bacterial biofilm formation inhibitory activity revealed for plant-derived natural compounds. Bioorg Med Chem 20: 920-926.
6. Asad S., Opal S (2008) Bench-to-bedside review: quorum sensing and the role of cell-to-cell communication during invasive bacterial infection. Crit Care 12: 236-246.
7. Baker DD, Chu M, Oza U., Rajgarhia V (2007) The value of natural products to future pharmaceutical discovery. Nat Prod Rep 24: 1225-1244.
8. Beenken KE, Dunman PM, McAleese F, Macapagal D, Murphy E, Projan SJ, Blevins JS., Smeltzer MS (2004) Global gene expression in Staphylococcus aureus biofilms. J Bacteriol 186: 4665-4684.
9. Boles BR., Horswill AR (2008) agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog 4: e1000052.
10. Boles BR., Horswill AR (2011) Staphylococcal biofilms disassembly. Trends Microbiol 19: 449-455.
11. Brackman G, Cos P, Maes L, Nelis HJ., Coenye T (2011) Quorum-sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob Agents Chemother 55: 2655-2661.
12. Brady RA, Leod JG, Camper AK, Costerton JW., Shirtliff ME (2006) Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to biofilm infection. Infect Immun 74: 3415-3426.
13. Brady RA, O'May GA, Leid JG, Prior ML, Costerton JW., Shirtliff ME (2011) Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment. Infect Immun 79: 1797-1803.
14. Chaignon P, Sadovskaya I, Ragunah C, Ramasubbu N, Kaplan JB., Jabbouri S (2007) Susceptibility of staphylococcal biofilms to enzymatic treatments depends on their chemical composition. Appl Microbiol Biotechnol 75: 125-132.
15. Chen M, Yu Q., Sun H (2013) Novel strategies for the prevention and treatment of biofilm-related infections. Int J Mol Sci 14: 18488-18501.
16. Chernousova S., Epple M (2013) Silver as antibacterial agent: ion, nanoparticle, and metal. Angew Chem Int Ed Engl 52: 1636- 1653.
17. Cirioni O, Giacometti A, Ghiselli R et al. (2006) RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter- associated Staphylococcus aureus infections. J Infect Dis 193: 180-186.
18. Conrady DG, Brescia CC, Horii K, Weiss AA, Hassett DJ., Herr AB (2008) A zinc-dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms. P Natl Acad Sci USA 105: 19456-19461.
19. Darouiche RO, Mansouri MD, Gawande PV., Madhyastha S (2009) Antimicrobial and antibiofilm efficacy of triclosan and DispersinB® combination. J Antimicrob Chemother 64: 88-93.
20. Davies DG., Marques CN (2009) A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J Bacteriol 191: 1393-1403.
21. de Beer D, Srinivasan R., Stewart PS (1994) Direct measurement of chlorine penetration into biofilms during disinfection. Appl Environ Microbiol 60: 4339-4344.
22. del Pozo JL., Patel R (2007) The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther 82: 204-209.
23. Donelli G, Franlini I, Romoli D, Guaglianone E, Piozzi A, Ragunath C., Kaplan JB (2007) Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother 51: 2733-2740.
24. Donlan RM (2002) Biofilms: microbial life on surfaces. Emerg Infect Dis 8: 881-890.
25. Donlan RM., Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167- 193.
26. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN., Kim JO (2000) A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 52: 662-668.
27. Francois P, Schrenzel J, Stoerman-Chopard C, Favre H, Hermann M, Foster TJ, Lew DP., Vaudaux P (2000) Identification of plasma proteins adsorbed on hemodialysis tubing that promote Staphylococcus aureus adhesion. J Lab Clin Med 135: 32-42.
28. Garrett TG, Bhakoo M., Zhang Z (2008) Bacterial adhesion and biofilms on surfaces. Prog Nat Sci 18: 1049-1056.
29. Harro JM, Peters BM, O'May GA, Archer N, Kerns P, Prabhakara R., Shirtliff ME (2010) Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration. FEMS Immunol Med Microbiol 59: 306-332.
30. Hoiby N, Bjarnsholt T, Givskov M, Molin S., Ciofu O (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35: 322-332.
31. Hoiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen PO, Molin S, Givskov M, Tolker-Nielsen T., Bjarnsholt T (2011) The clinical impact of bacterial biofilms. Int J Oral Sci 3: 55-65.
32. Hughes KA, Sutherland IW, Clark J., Jones MV (1998) Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology 144: 3039-3047.
33. Ito A, Taniuchi A, May T, Kawata K., Okabe S (2009) Increased antibiotic resistance of Escherichia coli in mature biofilms. Appl Environ Microbiol 75: 4093-4100.
34. Itoh Y, Wang X, Hinnebusch BJ, Preston JF., Romeo T (2005) Depolymerization of b-1,6-N-acetyl-D-glucosamine disrupts the integrity of diverse bacterial biofilms. J Bacteriol 187: 382-387.
35. Jennings JA, Courtney HS., Haggard WO (2012) Cis-2-decenoic acid inhibits S. aureus growth and biofilm in vitro: a pilot study. Clin Orthop Relat Res 470: 2663-2670.
36. Jermy A (2012) Biofilms: disassembly instructions included. Nat Rev Microbiol 10: 376.
37. Jia P, Xue Y, Duan X., Shao S (2011) Effect of cinnamaldehyde on biofilm formation and sarA expression by methicillin-resistant Staphylococcus aureus. Lett Appl Microbiol 53: 409-416.
38. Kalia V., Purohit H (2011) Quenching the quorum sensing system: potential antibacterial drug targets. Crit Rev Microbiol 37: 121- 140.
39. Kaplan JB, Ragunath C, Velliyagounder K, Fine DH., Ramasubbu N (2004) Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 48: 2633-2636.
40. Kelly D, McAuliffe O, Ross RP., Coffey A (2012) Prevention of Staphylococcus aureus biofilm formation and reduction in established biofilm density using a combination of phage K and modified derivatives. Lett Appl Microbiol 54: 286-291.
41. Kiedrowski MR., Horswill AR (2011) New approaches for treating staphylococcal biofilm infections. Ann NY Acad Sci 1241: 104- 121.
42. Kiran MD, Adikesavan NV, Cirioni A, Silvestri C, Scalise G, Ghiselli R, Saba V, Orlando F, Stoham M., Balaban N (2008) Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening. Mol Pharmacol 73: 1578-1586.
43. Klasen HJ (2000) A historical review of the use of silver in the treatment of burns. Part I Early uses. Burns 30: 1-9.
44. Kokai-Kun JF, Chanturiya T., Mond JJ (2009) Lysostaphin established Staphylococcus aureus biofilms in jugular vein catheterized mice. J Antimicrob Chemother 64: 94-100.
45. Kolodkin-Gal I, Romero D, Cao S, Clardy J, Kolter R., Losick R (2010) D-amino acids trigger biofilm disassembly. Science 328: 627-629.
46. Kong KF, Vuong C., Otto M (2006) Staphylococcus aureus quorum sensing in biofilm formation and infection. Int J Med Microbiol 296: 133-139.
47. Kwiecinski J, Eick S., Wojcik K (2009) Effects of tea tree (Melaleuca alternifolia) oil on Staphylococcus aureus in biofilms and stationary growth phase. Int J Antimicrob Agents 33: 343-347.
48. Kwon A, Park G, Ryu S, Lim DH, Lim DY, Choi C, Park Y., Lim Y (2008) Higher biofilm formation in multidrug-resistant clinical isolates of Staphylococcus aureus. Int J Antimicrob Agents 32: 68-72.
49. LaPlante KL, Sarkisian SA, Woodmansee S, Rowley DC., Seeram NP (2012) Effects of cranberry extracts on growth and biofilm production of Escherichia coli and Staphylococcus species. Phytother Res 26: 1371-1374.
50. Lewis K (2010) Persister cells. Annu Rev Microbiol 64: 357- 372.
51. Liu S, Yang S, Xu H, Qin L., Tay J (2004) The influence of cell and substratum surface on hydrophobicities on microbial attachment. J Biotechnol 110: 251-256.
52. Lynch AS., Abbanat D (2010) New antibiotic agents and approaches to treat biofilm-associated infections. Expert Opin Ther Pat 20: 1373-1387.
53. Mann EE, Rice KC, Boles BR, Endres JL, Ranjit D, Chandramohan T, Tsang LH, Smeltzer MS, Horswill AR., Bayles KW (2009) Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PLoS One 4: e5822.
54. Maira-Litran T, Kropec A, Abeygunawardana C, Joyce J, Mark G, Goldman DA., Pier GB (2002) Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect Immun 70: 4433-4440.
55. Masurkar SA, Chaudhari PR, Shidore VB., Kamble SP (2012) Effect of biologically synthesized silver nanoparticles on Staphylococcus aureus biofilm quenching and prevention of biofilm formation. IET Nanobiotechnol 6: 110-114.
56. Neut D, Kluin OS, Crielaard BJ, van der Mei HC, Busscher HJ., Grijpma DW (2009) A biodegradable antibiotic delivery system based on poly-(trimethylene carbonate) for the treatment of osteomyelitis. Acta Orthop 80: 514-519.
57. O'Neill E, Pozzi C, Houston P, Humphreys H, Robinson DA, Loughman DA, Foster TJ., O'Gara J (2008) A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J Bacteriol 190: 3835-3850.
58. Opperman TJ, Kwansny SM, Williams JD, Khan AR, Peet NP, Moir DT., Bowlin TL (2009) Aryl rhodanines specifically inhibit staphylococcal and entercoccal biofilm formation. Antimicrob Agents Chemother 53: 4357-4367.
59. Pan J., Ren D (2009) Quorum sensing inhibitors: a patent review. Expert Opin Ther Pat 19: 1581-1601.
60. Park H, Jang C, Cho Y., Choi C (2007a) Antibacterial effect of tea-tree oil on methicillin-resistant Staphylococcus aureus biofilm formation of the tympanostomy tube: an in vitro study. In Vivo 21: 1027-1030.
61. Park J, Jagasia R, Kaufmann GF, Mathison JC, Ruiz DI, Moss JA, Meijler MM, Ulevitch RJ., Janda KD (2007b) Infection control by antibody disruption of bacterial quorum sensing signaling. Chem Biol 14: 1119-1127.
62. Payne DE, Martin NR, Parzych KR, Rickard AH, Underwood A., Boles BR (2012) Tannic acid inhibits Staphylococcus aureus surface colonization in an IsaA-dependent manner. Infect Immunol 81: 496-504.
63. Peschel A., Otto M (2013) Phenol-soluble modulins and staphylococcal infections. Nat Rev Microbiol 11: 667-673.
64. Proctor RA (2012) Challenges for a universal Staphylococcus aureus vaccine. Clin Infect Dis 54: 1179-1186.
65. Quave CL, Estevez-Carmona M, Compadre CM, Hobby G, Hendrikson H, Beenken KE., Smeltzer MS (2012) Ellagic acid derivatives from Rubus ulmifolius inhibit Staphylococcus aureus biofilm formation and improve response to antibiotics. PLoS One 7: e28737.
66. Rahman M, Kim S, Kim SM, Seol SY., Kim J (2011) Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin. Biofouling 27: 1087- 1093.
67. Rai M, Yadav A., Gade A (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27: 76-83.
68. Ramos ER, Reitzel R, Juang Y et al. (2011) Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med 39: 245- 251.
69. Resch A, Leicht S, Saric M, Pasztor L, Jakob A, Gotz F., Nordheim A (2006) Comparative proteome analysis of Staphylococcus aureus biofilm and planktonic cells and correlation with transcriptome profiling. Proteomics 6: 1867-1877.
70. Savage VJ, Chopra I., O'Neill AJ (2013) Staphylococcus aureus biofilms promote horizontal transfer of antibiotic resistance. Antimicrob Agents Chemother 57: 1968-1970.
71. Schaffer AC., Lee JC (2009) Staphylococcal vaccines and immunotherapies. Infect Dis Clin North Am 23: 153-171.
72. Secinti KD, Ozalp H, Attar A., Sargon MF (2011) Nanoparticle silver ion coatings inhibit biofilm formation on titanium implants. J Clin Neurosci 18: 391-395.
73. Serrera A, del Pozo JL, Martinez A, Alonso M, Gonzalez R, Leiva J, Vergara M., Lasa I (2007) Dispersin B therapy of Staphylococcus aureus experimental port-related bloodstream infection. European Society of Clinical Microbiology and Infectious Disease (ESCMID), Munich, Germany.
74. Shahverdi AR, Fakhimi A, Sharverdi HR., Minaian S (2007) Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomed Nanotechnol Biol Med 3: 168-171.
75. Singh R, Ray P, Das A., Sharma M (2010) Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother 65: 1955-1958.
76. Son JS, Lee SJ, Jun SY, Yoon SJ, Kang SH, Paik HR, Kang JO., Choi YJ (2010) Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme. Appl Microbiol Biotechnol 86: 1439-1449.
77. Stevens KN, Crespo-Biel O, Van Den Bosch EE, Dias AA, Knetsch ML, Aldenhoff YB, van der Veen FH, Maessen JG, Stobberingh EE., Koole LH (2009) The relationship between the antimicrobial effect of catheter coatings containing silver particles and the coagulation of contacting blood. Biomaterials 30: 3682-3690.
78. Stoodley P, Nistico L, Johnson S, Lasko LA, Baratz M, Gahlot V, Ehrlich GD., Kathju S (2008) Direct demonstration of viable Staphylococcus aureus biofilms in an infected total joint arthroplasty: a case report. J Bone Joint Surg Am 90: 1751-1758.
79. Sutherland IW, Hughes KA, Skillman LC., Tait K (2004) The interaction of phage and biofilms. FEMS Microbiol Lett 232: 1-6.
80. Wright J, Lyon G, George E, Muir T., Novick R (2004) Hydrophobic interactions drive ligand-receptor recognition for activation and inhibition of staphylococcal quorum sensing. P Natl Acad Sci USA 101: 16168-16173.
81. Wu JA, Kusuma C, Mond JJ., Kokai-Kun JF (2003) Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 47: 3407-3414.
82. Xu KD, McFeters GA., Stewart PS (2000) Biofilm resistance to antimicrobial agents. Microbiology 146: 547-549.
83. Yamanaka M, Hara K., Kudo J (2005) Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol 71: 7589-7593.
84. Yang L, Liu Y, Wu H, Song Z, Hoiby N, Molin S., Givskov M (2011) Combating biofilms. FEMS Immunol Med Microbiol 65: 146-157.